Analyzing 13C Tracing Data
The Five Steps
| Step | What happens | Decision that matters |
|---|---|---|
| 1. Peak extraction | Fragment or parent masses converted to intensities | Which adduct and fragment to use |
| 2. Natural abundance correction | Remove the ¹³C contributed by unlabelled atoms | Which correction algorithm |
| 3. Mass isotopomer distribution | Fraction of each mass in each metabolite | Whether to include the lowest mass |
| 4. Model definition | Network, compartments, exchange reactions | How much compartmentation to include |
| 5. Fitting | Optimise fluxes to match the MIDs | Whether the data constrain the parameters |
Important distinction. Steps 1–3 produce a description of labelling. Steps 4–5 produce a flux estimate. Many "flux analysis" papers stop at step 3, and the resulting numbers are labelled fractions with flux units attached.
Part 1 — Natural Abundance and Its Traps
| Issue | Detail |
|---|---|
| Carbon natural abundance | ~1.1% ¹³C, which produces a non-zero baseline in every mass channel |
| Correction algorithm | Different algorithms give slightly different results at high label fractions |
| Low-enrichment samples | Small differences are dominated by the correction |
| Over-correction | Applying a correction to data already background-subtracted |
| Fragment-specific abundance | Some fragments include atoms with different abundance contributions |
Readout note. The lowest mass isotopologue (m+0) is often discarded because it is dominated by unlabelled material. That is acceptable for relative comparisons, but it removes information needed for mass balance, and an MFA fit that omits m+0 estimates fewer parameters than the network requires.
Part 2 — Steady State and Time
| Assumption | How to check | What happens if violated |
|---|---|---|
| Isotopic steady state | MIDs stable across two timepoints | Fluxes describe a transient |
| Metabolic steady state | Pools and extracellular rates stable | The model has no unique solution |
| No recycling | Label does not return via a different route | Overestimated flux in the labelled route |
| Complete mixing of the tracer | Precursor enrichment known | Fluxes scaled incorrectly |
Important distinction. Isotopic steady state is not metabolic steady state. A cell can reach stable labelling while its pool sizes are changing, and it can have stable pools while labelling is still evolving. Both need checking, and they are checked differently.
Part 3 — Model Definition
| Decision | Options | Consequence |
|---|---|---|
| Compartmentation | Single pool versus cytosolic/mitochondrial | Single-pool models misassign mitochondrial fluxes |
| Exchange reactions | Include or omit | Omitting them forces net flux to equal label flux |
| Biomass drain | Include a growth term or not | Otherwise carbon accumulates in the model |
| Reversible steps | Specify reversibility | Reversibility changes label distribution substantially |
| Tracer mixture | One tracer versus several | Multiple tracers improve identifiability |
Caveat on identifiability. A model with more fluxes than the data can constrain produces a fit with wide or undefined confidence intervals. That is not a numerical problem to be worked around; it is a statement that the experiment cannot answer the question. Reporting a single best-fit value without intervals hides it.
Part 4 — Software and Practicalities
| Tool | Strengths | Note |
|---|---|---|
| INCA | Widely used; MFA with isotopomers | Requires a defined network |
| OpenFLUX / 13CFLUX2 | Open source; flexible | Steeper learning curve |
| Custom scripts | Full control | Reproducibility burden |
| Mid-correction tools (e.g. IsoCorrectoR) | Handles natural abundance for metabolomics | Not an MFA tool |
Readout note. Whatever the tool, the analysis should report: the tracer, the enrichment, the timepoints, the MID data, the network as supplied, the fit residuals, and confidence intervals. Without these, the result cannot be reproduced or evaluated.
Part 5 — Common Failures
- • Labelled fractions reported as fluxes.
- • Natural abundance not corrected, or corrected twice.
- • Single timepoint used as if it were steady state.
- • Single-pool model applied to a compartmented pathway.
- • Exchange reactions omitted, so reversibility is invisible.
- • No confidence intervals.
- • Precursor enrichment assumed rather than measured.
- • Network not reported, so the model cannot be checked.
- • Fits reported without residuals.
Part 6 — Where This Article Connects
This is the workflow article for the mitochondrial cluster: the tracing-principles article covers tracer choice, and this one covers what happens to the data afterwards. The citrate and succinate patterns discussed in the pillar are the inputs, and the oncometabolite article uses the same workflow for 2-HG.
If you need tracing analysed with a reported network and confidence intervals, we can scope the analysis with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Correction algorithms, model structure and identifiability depend on the tracer, the analytical platform and the network supplied; results are specific to that combination.
A mass isotopomer distribution is a description of labelling; a flux estimate requires a model, extracellular rates and an assessment of identifiability.
Scientific interpretation and experimental design
- • Five steps, three of them descriptive.
- • Correct for natural abundance once.
- • Check steady state twice. Isotopic and metabolic.
- • Compartmentation changes the answer.
- • Report the network.
- • No intervals, no flux claim.
Selected references for further reading
- • Antoniewicz MR. A guide to ¹³C metabolic flux analysis for the cancer biologist. Experimental & Molecular Medicine. 2018;50:1–13.
- • Young JD. INCA: a computational platform for isotopically non-stationary metabolic flux analysis. Bioinformatics. 2014;30:1333–1335.
- • Wiechert W, et al. OpenFLUX: efficient modelling software for ¹³C-based metabolic flux analysis. Microbial Cell Factories. 2009;8:25.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »